Published by
@ShahidNShah
@ShahidNShah
Artificial pancreas effectively controls type 1 diabetes in children age 6 and up
A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system – which automatically monitors and regulates blood glucose levels – is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Results from the trial were published August 26 in the New England Journal of Medicine.
Continue reading at sciencedaily.com
Make faster decisions with community advice
- AI-assisted EHR documentation will need human help
- Amazon releases wearable health tracker with app called Amazon Halo
- Femtech market has potential but struggles to score investor dollars
- Pay Mental Wellness Forward During Mental Health Awareness Week
- Proposal for HIPAA Modifications Coming by Year's End
Next Article
-
Femtech market has potential but struggles to score investor dollars
Women’s health startups are starting to garner a lot of attention. However, a new report out of PitchBook found that the industry is still struggling to catch the attention of VCs, and …
Posted Aug 31, 2020 Women In Technology FemTech
